ODDB.org: Open Drug Database

UCB-Pharma SA - Vimpat 200 mg, comprimés pelliculés

Swissmedic Registration	59002	Sequence	04
Product name	Vimpat 200 mg	Description	comprimés pelliculés
ATC-Classification	N03AX18	ATC-Description	Lacosamide
Introduction of Sequence	28.08.2009

Composition

lacosamidum 200 mg, cellulosum microcristallinum, hydroxypropylcellulosum substitutum humile, cellulosum microcristallinum silicificatum, crospovidonum, magnesii stearas, hydroxypropylcellulosum, pellicule: poly(alcohol vinylicus), talcum, macrogolum 3350, E 132, E 171 pro compresso obducto.

Packungsbestandteile

Galenic Form

Coated tablets

Active Agent	Dose
Lacosamidum	200 mg

BAG: Active Agent	Dose
Lacosamidum	200 mg

Inactive agents	Dose	additional_information
Cellulosum Microcristallinum
Cellulosum Microcristallinum Silicificatum
Crospovidonum
E 132		color.
E 171		color.
Hydroxypropylcellulosum
Hydroxypropylcellulosum Substitutum Humile
Macrogol	3350
Magnesii Stearas
Poly(Alcohol Vinylicus)		pellicule
Pro Compresso Obducto
Talcum

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
007	14 Tablet(s)	21.04	39.30	B	SL	Yes
008	168 Tablet(s)	233.86	270.75	B	SL	Yes
015	56 Tablet(s)	79.94	103.35	B	SL	Yes

2025	©ywesee GmbH